Xi Jin
6PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 10, 2025
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.Tong Fu, Xi Jin, Min He
|Aug 18, 2025
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.Xiu-Zhi Zhu, Hu-Yun-Long Zhang, Yi-Fan Zhou
|Aug 26, 2024
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.Yu-Wei Li, Lei-Jie Dai, Xiang-Rong Wu
|May 02, 2023
Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer.Wen-Ting Peng, Xi Jin, Xiao-En Xu
|Apr 15, 2023
Calcifications in triple-negative breast cancer: Molecular features and treatment strategies.Cai-Jin Lin, Wen-Xuan Xiao, Tong Fu
|Mar 12, 2019
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.Xi Jin, Xiao-En Xu, Yi-Zhou Jiang
Pageof 1
Frequent Collaborators
5 joint publications
Zhi-Ming Shao
4 joint publications
Yi-Zhou Jiang
3 joint publications
Tong Fu
2 joint publications
Xiao-En Xu
2 joint publications
Zhi-Ming Shao
2 joint publications
Yi-Fan Zhou
2 joint publications
Hu-Yun-Long Zhang
2 joint publications
Cai-Jin Lin
2 joint publications
Ding Ma
2 joint publications
Yun-Song Yang
